Clinical Evaluation of FreeO2 (Version 4) in All Patients Receiving Oxygen
FreeO24G
Clinical Evaluation of the Automatic Oxygen Adjustment by FreeO2 in a Medical Population in Hospital
1 other identifier
interventional
50
1 country
1
Brief Summary
Evaluation of automatic titration of oxygen with a new version of FreeO2 (V4)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 30, 2017
CompletedFirst Submitted
Initial submission to the registry
April 12, 2017
CompletedFirst Posted
Study publicly available on registry
April 19, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 6, 2020
CompletedJune 20, 2024
June 1, 2024
2.2 years
April 12, 2017
June 17, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
% of time in the set SpO2 target
Continuous SpO2 monitoring (1 data each second) will be recorded, the % of time within the SpO2 target±2% set by the physician will be considered (Time in the target±2/Total recording time)
During 3 days of hospitalization or until Oxygen weaning
Secondary Outcomes (1)
Oxygenation data
3 hospitalisations day or until Oxygen weaning
Study Arms (1)
Automated oxygen adjustment
OTHERAll patient in this study have automatic oxygen titration and automatic oxygen weanning
Interventions
All include patients will have automatic administration of oxygen by FreeO2 up to 3 day or until weaning of oxygen adminisatrion
Eligibility Criteria
You may qualify if:
- Age \> or = 18 years old
- Patient receiving oxygen between 1 to 6 lpm for medical pathology
- Admitted to a medical service for less than 72 hours (emergency room not included)
You may not qualify if:
- Unreliable SpO2 signal
- Emergency or intensive care hospitalization
- Absence of NIV or intubation criteria at baseline
- Sleep apnea not paired
- Long-term Oxygen Therapy
- Active delirium and cognitive impairment preventing informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Laval Universitylead
Study Sites (1)
IUCPQ-UL
Québec, Quebec, G1V4G5, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 12, 2017
First Posted
April 19, 2017
Study Start
January 30, 2017
Primary Completion
April 30, 2019
Study Completion
November 6, 2020
Last Updated
June 20, 2024
Record last verified: 2024-06